Initial experience of Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography imaging in evaluation of biochemical recurrence in prostate cancer patients
Aravintho Natarajan(Tata Memorial Hospital), Venkatesh Rangarajan(Tata Memorial Hospital), Vedang Murthy(Homi Bhabha National Institute), Ganesh Bakshi(P. D. Hinduja Hospital and Medical Research Centre), Amit Joshi(Dr. Rajendra Prasad Government Medical College), Sneha Shah(Tata Memorial Hospital), Archi Agrawal(Tata Memorial Hospital), Nilendu Purandare(Tata Memorial Hospital), Ameya Puranik(Homi Bhabha National Institute)
Cited by 16
Related Papers
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
|European Journal of Nuclear Medicine and Molecular Imaging|2011|377
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
|Journal of Clinical Oncology|2017|340